BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna has entered into value-based pharmaceutical contracts with Amgen and Sanofi/Regeneron for their PCSK9 inhibitors. The contracts align financial incentives to improved customer health.
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
